Arrowhead Pharmaceuticals

graphic image of different colored hands shaking
Biotech

Sarepta, Arrowhead ink $1B-plus deal for seven programs

Sarepta is paying Arrowhead $500 million in cash, plus a $325 million equity investment, for worldwide licensing rights to seven programs.
Gabrielle Masson Nov 26, 2024 11:18am
photo of a royal flush laid out on the poker table with chips scattered nearby

Arrowhead posts phase 3 data ahead of market clash with Ionis

Sep 3, 2024 9:27am
pond lilly pads

Arrowhead dips toes into obesity pond with 2 preclinical assets

Aug 14, 2024 3:50pm
Directions

Arrowhead axes one heart disease drug, goes all in on another

Jun 26, 2024 7:00am
fence palisade wall defense fence gate fortress fort

Arrowhead RNAi med lowers triglycerides in phase 3

Jun 3, 2024 9:54am
arrow target quiver aim shoot ammo

Arrowhead's cholesterol drug hits the mark again in ph. 2 trial

May 28, 2024 9:13am